Allogeneic hematopoetic stem cell transplant for patients with refractory T‐Cell lymphomas

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project

(2021) Andrei Shustov et al.   Blood Advances

The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas

(2021) Kennosuke Karube et al.   Expert Review of Hematology

Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

(2021) Emmanuel Bachy et al.   JOURNAL OF CLINICAL ONCOLOGY

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

(2021) S. Horwitz et al.   ANNALS OF ONCOLOGY

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

(2020) Anne-Claire Mamez et al.   Journal of Hematology & Oncology

First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients

(2019) Andrea Janikova et al.   ANNALS OF HEMATOLOGY

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients

(2019) David Sibon et al.   HAEMATOLOGICA

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

(2018) Mary Gleeson et al.   Lancet Haematology

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

(2018) Steven Horwitz et al.   LANCET

The role of stem cell transplant for lymphoma in 2017

(2017) John G. Gribben   HEMATOLOGICAL ONCOLOGY

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma

(2017) Matthew J. Maurer et al.   JOURNAL OF CLINICAL ONCOLOGY

Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study

(2017) Tanya Skamene et al.   LEUKEMIA & LYMPHOMA

Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States

(2016) Scott V. Adams et al.   JOURNAL OF CLINICAL ONCOLOGY

First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation

(2016) M Wilhelm et al.   Blood Cancer Journal

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) F. d'Amore et al.   ANNALS OF ONCOLOGY

Can a Female Donor for a Male Recipient Decrease the Relapse Rate for Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation?

(2015) Piyanuch Kongtim et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

(2015) C. Kollman et al.   BLOOD

Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center

(2014) M. Loirat et al.   ANNALS OF ONCOLOGY

Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry

(2014) F. Ellin et al.   BLOOD

Graft-versus-T-cell lymphoma effect: a sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic transplantation

(2014) A C Mamez et al.   BONE MARROW TRANSPLANTATION

Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30+ Peripheral T-Cell Lymphomas: Results of a Phase I Study

(2014) Michelle A. Fanale et al.   JOURNAL OF CLINICAL ONCOLOGY

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

(2014) Bruce D. Cheson et al.   JOURNAL OF CLINICAL ONCOLOGY

Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma

(2014) P Corradini et al.   LEUKEMIA

Autologous Stem Cell Transplantation as the First-Line Treatment for Peripheral T Cell Lymphoma: Results of a Comprehensive Meta-Analysis

(2013) J. Yin et al.   ACTA HAEMATOLOGICA

Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)

(2013) W. Saber et al.   BLOOD

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

(2013) M. Schmidt-Hieber et al.   BLOOD

Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors

(2013) S. Servais et al.   HAEMATOLOGICA

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

(2013) Sonali M. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials

(2012) David Sibon et al.   JOURNAL OF CLINICAL ONCOLOGY

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

(2012) Francesco d'Amore et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology

(2012) S-W Kim et al.   LEUKEMIA

Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure

(2011) César O. Freytes et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

(2011) D. D. Weisenburger et al.   BLOOD

Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect

(2011) A Dodero et al.   LEUKEMIA

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

(2010) N. Schmitz et al.   BLOOD

Defining the Intensity of Conditioning Regimens: Working Definitions

(2009) Andrea Bacigalupo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2009) Charalampia Kyriakou et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies

(2009) Junya Kanda et al.   TRANSFUSION

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma

(2008) S. Mercadal et al.   ANNALS OF ONCOLOGY

Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T Cell Lymphomas; Evidence of Graft-Versus-T Cell Lymphoma Effect

(2008) Mehdi Hamadani et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

(2008) K. J. Savage et al.   BLOOD

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

(2008)   JOURNAL OF CLINICAL ONCOLOGY

Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study

(2008) Peter Reimer et al.   JOURNAL OF CLINICAL ONCOLOGY